Karl Doghramji
Sleep Medicine · Philadelphia, PANPI 1336229459
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $68,045 of the $84,594 with a category attached, or 80.4%. 16 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 25.6% of the total. Reporting peaked in 2021 at $21,891 and has fallen 96.3% since, to $814 in 2025. Among sleep medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $950.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$22K
- Eisai Inc.$18K
- Harmony Biosciences LLC$16K
- Idorsia Pharmaceuticals US Inc$14K
- Imbrium Therapeutics L.p.$5K
- Biogen$3K
- plus $8K from 10 others
Across 2 payments — averaging $10,225 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$20K
What the payments were for
- Consulting fees$68,04580%
- Speaking & faculty fees$10,90913%
- Travel & lodging$3,6324%
- Food & beverage$1,5902%
- Education$4180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 24 | $21,620 |
| Eisai Inc. | 30 | $17,924 |
| Harmony Biosciences LLC | 13 | $16,124 |
| Idorsia Pharmaceuticals US Inc | 5 | $13,737 |
| Imbrium Therapeutics L.p. | 2 | $4,500 |
| Biogen | 1 | $3,101 |
| Natus Medical Incorporated | 3 | $3,000 |
| Janssen Scientific Affairs, LLC | 1 | $2,904 |
| Pfizer | 1 | $700 |
| Inspire Medical Systems, Inc. | 1 | $650 |
| ZOLL Respicardia, Inc. | 1 | $141 |
| AbbVie | 3 | $105 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $42 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wakix$15,963
- QUVIVIQ$13,703
- XYREM$6,077
- Dayvigo$4,920
- XYWAV$2,833
- CELEBREX$700
- Inspire Upper Airway Stimulation System$650
- remede System$141
How this compares
$84,594 in reported general payments places this provider in the 95th percentile of 87 sleep medicine providers in Pennsylvania.
Other sleep medicine in Philadelphia
- Richard SchwabPhiladelphia$81K
- Nalaka GooneratnePhiladelphia$11K
- Neil DoshiPhiladelphia$6K
- Ritu GrewalPhiladelphia$4K
- Katherine MoawadPhiladelphia$3K
- Raj DedhiaPhiladelphia$3K
- Kunal KumarPhiladelphia$2K
- Jorge MoraPhiladelphia$2K
- Jie Min Leonard SohPhiladelphia$2K
- Zhikui WeiPhiladelphia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.